Singular Genomics Systems, Inc. Common Stock
OMIC
OMIC was delisted on the 20th of February, 2025.
52 hedge funds and large institutions have $312M invested in Singular Genomics Systems, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 18 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 6
6% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 18
0% more funds holding
Funds holding: 52 → 52 (0)
59% less capital invested
Capital invested by funds: $757M → $312M (-$445M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$9.8M |
| 2 |
Millennium Management
New York
|
+$4.15M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.03M |
| 4 |
JP Morgan Chase
New York
|
+$2.98M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$13.7M |
| 2 |
PVI
Pura Vida Investments
New York
|
-$4.29M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.96M |
| 4 |
Goldman Sachs
New York
|
-$2.06M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.48M |
OMIC Hedge Fund Activity: Q3 2021 in Review
52 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q3 2021, worth a combined $312M — down 59% from $757M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new OMIC positions and 18 closed out — a net gain of 1 holder — while 18 added to existing stakes and 6 trimmed.
The largest buyer was BlackRock, adding an estimated $9.8M. The largest seller was Franklin Resources, exiting entirely with an estimated $13.7M sold.
- 52 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $312M of Singular Genomics Systems, Inc. Common Stock stock for Q3 2021, down 59% quarter-over-quarter.
- 19 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q3 2021 and 18 closed out, a net change of +1 holder.
- The largest Singular Genomics Systems, Inc. Common Stock buyer in Q3 2021 was BlackRock, an estimated $9.8M added.
- The largest Singular Genomics Systems, Inc. Common Stock seller in Q3 2021 was Franklin Resources, an estimated $13.7M sold.
Based on aggregated 13F filings for Q3 2021.